Purchases and Sales Made in Q4 2021 in Can Fite Bio Pharma Ltd. (CANF)
This table provides information about the institutional ownership of Can Fite Bio Pharma Ltd. (CANF) during Q4 2021. The information is specifically focused on institutions that hold shares of Can-Fite BioPharma Ltd..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2022
Q4 2021
|
Morgan Stanley
New York, NY |
BUY
|
- |
41.8K+ 21.24% |
$40.9K - $89.8K
|
238K
$467K
|
|
|
Feb 14, 2022
Q4 2021
|
Two Sigma Securities, LLC
New York, NY |
BUY
|
- |
17.8KNew |
$17.5K - $38.3K
|
17.8K
$34.9K
|
|
|
Feb 14, 2022
Q4 2021
|
Hrt Financial LP
New York, NY |
BUY
|
- |
11.9KNew |
$11.7K - $25.6K
|
11.9K
$23.3K
|
|
|
Jan 24, 2022
Q4 2021
|
National Bank Of Canada
|
BUY
|
- |
6KNew |
$5.88K - $12.9K
|
6K
$11.8K
|
|
|
Feb 08, 2022
Q4 2021
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
499New |
$489 - $1.07K
|
499
$978
|
|
|
Nov 13, 2023
Q4 2021
|
Td Waterhouse Canada Inc.
Toronto, A6 |
BUY
|
- |
203New |
$199 - $436
|
203
$398
|
|
|
Feb 07, 2022
Q4 2021
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 10, 2022
Q4 2021
|
Acadian Asset Management LLC
Boston, MA |
SELL
|
- |
-86.2K- 75.09% |
$84.5K - $185K
|
28.6K
$56.1K
|
|
|
Feb 11, 2022
Q4 2021
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-93.4KClosed |
$91.5K - $201K
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Armistice Capital, LLC
New York, NY |
SELL
|
- |
-875KClosed |
$858K - $1.88M
|
0
$0
|